Found 30 matching trials
Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD PHASE2 Phase II multicenter, Canadian only study - open to 25 subjects. Study open...
Show More Location
Hospital Maissoneuve
Learn More & Join Trial
A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma PHASE2 The purpose of this study is to find out whether the combination of botensi...
Show More Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial
Donor Regulatory T-cells for cGVHD in Patients Who do Not Obtain Complete Remission With Ruxolitinib PHASE2 Phase II clinical trial to assess the efficacy of donor regulatory enriched...
Show More Location
José Antonio Pérez Simón
Learn More & Join Trial
Ipilimumab Administered to Stage IIIC Stage IV Melanoma After Reg. T Cell Depletion With Denileukin Diftitox PHASE2 This is an open-label, clinical efficacy study of Ipilimumab in patients wi...
Show More Location
James Graham Brown Cancer Center
Learn More & Join Trial
Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer PHASE1 RATIONALE: Combinations of biological substances in denileukin diftitox may...
Show More Location
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Learn More & Join Trial
Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG PHASE1 This phase I/II trials evaluates the feasibility, safety and efficacy of an...
Show More Location
University Children's Hospital
Learn More & Join Trial
Multiple Donor Treg DLI for Severe Refractory Chronic GVHD PHASE1 This is a INTERVENTIONAL TRANSPLANTATION STUDY WITHOUT DRUGS.
The INTERVEN...
Show More Location
University Hospital St. Orsola-Malpighi Polyclinic
Learn More & Join Trial
Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma PHASE2 This randomized phase II trial is studying how well giving vaccine therapy ...
Show More Location
National Cancer Institute Surgery Branch
Learn More & Join Trial
Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma PHASE2 RATIONALE: An infusion of a patient's lymphocytes that have been treated in...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Learn More & Join Trial
Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma PHASE2 This randomized phase II trial is studying how well giving vaccine therapy ...
Show More Location
University of Chicago Comprehensive Cancer Center
Learn More & Join Trial